跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tapcom - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tapcom
Approved
STANDARD
Tapcom
Santen Pharmaceutical Co., Ltd. (Shiga Plant)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a213b4acd0f7948a
Company
Santen Pharmaceutical Co., Ltd. (Shiga Plant)
Type
Standard
Approval Details
Approval Id
a213b4acd0f7948a
Drug Approval Philippines Name
Tapcom
Product Name
Tapcom
Registration Number
DR-XY46011
Brand Name
Tapcom
Generic Name
Tafluprost + Timolol (As Maleate)
Dosage Form
Ophthalmic Solution
Dosage Strength
15 mcg/ 5 mg per mL
Manufacturer
Santen Pharmaceutical Co., Ltd. (Shiga Plant)
Importer
Santen Philippines Inc.
Issuance Date
25 October 2022
Expiry Date
11 September 2027
Pharmacologic Category
Antiglaucoma
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a213b4acd0f7948a
Type
Standard
Back to Philippines FDA Approvals